Dentsply Sirona (NASDAQ: XRAY) director reports 341-share RSU dividend

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Gregory T. Lucier reported an automatic award of additional common stock tied to existing restricted stock units. On 01/09/2026, an entity described as a family partnership associated with him received 341.114 shares of common stock at a price of $0, reflecting dividends on his restricted stock units that were paid in the form of additional RSUs.

After this transaction, the family partnership held 24,901.284 common shares indirectly. Separately, an IRA associated with Gregory Lucier held 21,000 common shares indirectly, while his direct common stock holdings were reported as zero. The footnote explains that these dividend RSUs follow the same vesting schedule as the underlying RSU awards and each RSU converts into one share of common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LUCIER GREGORY T

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		A		341.114(1)	A	$0	24,901.284	I	By Family Partnership
Common Stock								0	D
Common Stock								21,000	I	By Gregory Lucier IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Gregory T. Lucier	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DENTSPLY SIRONA (XRAY) disclose about Gregory T. Lucier in this Form 4?

The filing shows that director Gregory T. Lucier, through a family partnership, received 341.114 shares of DENTSPLY SIRONA common stock as dividend-related restricted stock units on 01/09/2026.

How many DENTSPLY SIRONA shares does the family partnership hold after the reported transaction?

Following the transaction, the family partnership associated with Gregory Lucier held 24,901.284 shares of DENTSPLY SIRONA common stock indirectly.

What is the nature of the 341.114-share award reported for XRAY?

The 341.114 shares represent dividends on existing restricted stock units, paid in the form of additional RSUs that carry the same vesting terms as the original awards and convert to common stock on a 1:1 basis.

Did Gregory T. Lucier pay anything for the 341.114 DENTSPLY SIRONA shares?

No cash was paid for this award; the transaction shows 341.114 common shares acquired at a price of $0, reflecting RSU dividend accruals rather than an open-market purchase.

How many DENTSPLY SIRONA shares are held in Gregory Lucier’s IRA?

The Form 4 reports that an IRA associated with Gregory Lucier indirectly holds 21,000 shares of DENTSPLY SIRONA common stock.

Does Gregory T. Lucier report any direct ownership of DENTSPLY SIRONA common stock?

The filing lists 0 shares as directly held common stock, while his reported holdings are indirect through a family partnership and an IRA.

How do the RSU dividends for XRAY vest according to this Form 4?

The RSU dividend units are subject to the same vesting terms as the underlying RSUs, and the dividends vest simultaneously with those underlying awards.